Financial Performance - Operating revenue for the first nine months of 2023 was CNY 247,323,781.42, down 9.57% from CNY 273,488,425.58 in the same period last year[8] - Net profit attributable to shareholders for the first nine months of 2023 was CNY 32,150,076.89, a decline of 40.65% compared to CNY 54,168,550.00 in the previous year[8] - Basic earnings per share for the first nine months of 2023 were CNY 0.4720, down 67.46% from CNY 1.4503 in the same period last year[8] - In Q3 2023, operating revenue increased by 13.77% to CNY 81,646,706.56 compared to CNY 71,766,085.92 in Q3 2022[8] - The net profit attributable to shareholders in Q3 2023 was CNY 10,122,142.98, a decrease of 3.70% from CNY 10,511,315.21 in Q3 2022[8] - Total operating revenue for the first nine months of 2023 was CNY 247,323,781.42, a decrease of 9.57% compared to CNY 273,488,425.58 in the same period of 2022[33] - Net profit for the first nine months of 2023 was CNY 31,860,085.53, down 41.00% from CNY 54,168,550.00 in the same period of 2022[34] - Operating profit decreased to ¥30,211,781.52 from ¥63,331,913.98, a decline of about 52.3%[38] - Net profit fell to ¥28,304,441.60 compared to ¥56,085,227.64, representing a decrease of approximately 49.6%[38] Cash Flow - Cash flow from operating activities for the first nine months of 2023 was CNY 24,140,944.82, a decrease of 6.87% compared to CNY 25,921,801.66 in the previous year[8] - Cash flow from operating activities generated ¥24,140,944.82, slightly down from ¥25,921,801.66, a decrease of about 6.9%[41] - Cash inflow from investment activities totaled $972,218,239.90, significantly up from $91,904,409.51, indicating an increase of over 956%[44] - Net cash flow from investment activities was $159,541,715.59, a turnaround from a negative $12,372,651.70 in the previous period[44] - The net increase in cash and cash equivalents was $137,540,575.25, contrasting with a decrease of $5,599,251.28 in the prior period[44] - Total cash outflow from operating activities was $242,449,566.28, down from $286,096,501.04, indicating a decrease of about 15%[44] Assets and Liabilities - Total assets as of September 30, 2023, amounted to CNY 609,678,373.53, a decrease of 0.35% compared to the end of 2022[8] - The company’s total liabilities to total assets ratio was 15.84% as of September 30, 2023, compared to 15.34% at the end of the previous year[8] - Total current assets decreased to CNY 487.51 million as of September 30, 2023, down from CNY 552.69 million at the end of 2022, representing a decline of approximately 11.8%[25] - Total liabilities increased to CNY 96.55 million from CNY 93.87 million, marking an increase of 1.8%[27] - Total liabilities decreased to CNY 72,722,890.94 in 2023 from CNY 85,559,047.44 in 2022, reflecting a reduction of approximately 15.00%[31] - Total equity decreased to CNY 506,220,717.41 in 2023 from CNY 516,052,284.17 in 2022, indicating a decline of about 1.61%[31] Shareholder Information - The total number of ordinary shares at the end of the period was 68,109,800 shares[16] - The largest shareholder, Zhang Wen, holds 56.40% of the shares, totaling 38,415,283 shares[17] - The proportion of limited sale shares is 75%, totaling 51,080,400 shares[16] - The company has no pledges or judicial freezes on shares held by shareholders with over 5% ownership[19] - The number of ordinary shareholders at the end of the period was 11,635[16] Government and Other Income - The total amount of government subsidies recognized in the current period was 1,592,713.08 yuan[13] - The total non-recurring gains and losses amounted to 7,222,872.07 yuan after tax[14] - The fair value changes from trading financial assets and derivatives resulted in a gain of 6,561,404.27 yuan[13] - The company reported a total of CNY 6,979,720.00 in other income for the first nine months of 2023, down from CNY 8,482,474.81 in the same period of 2022[34] Research and Development - Research and development expenses for the first nine months of 2023 were CNY 15,741,393.07, an increase of 11.61% compared to CNY 14,102,700.02 in the same period of 2022[34] - R&D expenses increased to ¥15,741,393.07 from ¥14,102,700.02, reflecting a growth of approximately 11.6%[38] Future Plans - The company plans to focus on expanding its market presence and investing in new technologies to drive future growth[28] - The company plans to focus on market expansion and new product development to drive future growth[34]
倍益康(870199) - 2023 Q3 - 季度财报